Treating or preventing extracellular matrix build-up

Details for Australian Patent Application No. 2005222085 (hide)

Owner Regenerx Biopharmaceuticals, Inc.

Inventors Goldstein, Allan L.

Agent Wrays

Pub. Number AU-B-2005222085

PCT Pub. Number WO2005/087805

Priority 60/549,911 05.03.04 US

Filing date 7 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 6 January 2011

International Classifications

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/087805 Priority application(s): WO2005/087805

9 November 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 19 Oct 2006

6 January 2011 Application Accepted

  Published as AU-B-2005222085

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222092-Method and device for continuously forming optical fiber connector glass and other close tolerance components

2005222084-Multiple promoter expression cassettes for simultaneous delivery of RNAI agents